Suppression of CSF1R expression both in diabetes-free and especially in diabetes tumors seems to be counter-productive for the malignancy via decreasing the influx of immunosuppressive tumor-associated macrophages (TAM) which in turn compromise antitumor activities of CD8+ cytotoxic lymphocytes [35]. The gene discussed is CD8A; the disease is diabetes mellitus.